Impact of gender, weight and CYP2B6 genotype on efavirenz exposure in patients on HIV/AIDS and TB treatment: Implications for individualising therapy

Tafireyi Nemaura; Charles Nhachi; Collen Masimirembwa

doi:10.5897/AJPP12.076

African Journal of
Pharmacy and Pharmacology

Abbreviation: Afr. J. Pharm. Pharmacol.
Language: English
ISSN: 1996-0816
DOI: 10.5897/AJPP
Start Year: 2007
Published Articles: 2288

Full Length Research Paper

Impact of gender, weight and CYP2B6 genotype on efavirenz exposure in patients on HIV/AIDS and TB treatment: Implications for individualising therapy

Tafireyi Nemaura1,2, Charles Nhachi1 and Collen Masimirembwa2*

1Department of Clinical Pharmacology, College of Health Sciences, University of Zimbabwe, Zimbabwe. 2Department of DMPK/PD-BAC, African Institute of Biomedical Science and Technology, Zimbabwe.
Email: [email protected], [email protected]

Article Number - 14D394933005
Vol.6(29), pp. 2188-2193 , August 2012
https://doi.org/10.5897/AJPP12.076

Accepted: 10 March 2012
Published: 08 August 2012

Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.